[In vitro induction of PHA-activated killer cells for adoptive immunotherapy of recurrent or residual malignant gliomas].
D001932:Brain Neoplasms / Q000628:therapy*; D005910:Glioma / Q000628:therapy*; D006801:Humans; D007116:Immunization, Passive; D066298:In Vitro Techniques; D007376:Interleukin-2 / Q000494:pharmacology; D007694:Killer Cells, Natural / Q000276:immunology*; D008213:Lymphocyte Activation / Q000187:drug effects*; D010835:Phytohemagglutinins / Q000494:pharmacology; D011994:Recombinant Proteins
D007376:Interleukin-2; D010835:Phytohemagglutinins; D011994:Recombinant Proteins